The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. All quotes are in local exchange time. Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. Privacy Notice, and Antares Pharma to Present at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference. ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. All rights reserved. 2019-10-18 seekingalpha.com - The share price action of Antares Pharma, Inc. (ATRS) (Medical Instruments & Supplies Firm) since late April definitely brings opportunities to the table for short-term traders. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Antares Pharma, Inc., which has a market valuation of $525.7 Million as of writing, is expected to release its quarterly earnings report on 44140. A company profile for Antares Pharma, Inc, including a description, key executives, stock price history and more. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. Antares Pharma Inc. had a pretty Dodgy run when it comes to the market performance. The company was founded in February 1979 and is headquartered in Ewing, NJ. Antares Pharma Inc.’s Net Margin is presently recorded at -1.64. Intraday data delayed at least 15 minutes or per exchange requirements. Stock analysis for Antares Pharma Inc (AIS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. In the following paragraphs, we find out […], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式!. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Intraday Data provided by FACTSET and subject to terms of use. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma, Inc. Common Stock (ATRS) Nasdaq 8/3/2020. Share your opinion and gain insight from other stock traders and investors. A high-level overview of Antares Pharma, Inc. (ATRS) stock. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. low after FDA letter late Thursday, Bearish bets against Tesla stock have fallen to a record low, data provider says, Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack, Stocks close higher for fifth straight session as Dow reclaims 25,000-level, Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector, Stock market ends, day week with a gain; Nasdaq logs 57th all-time high, Antares Pharma stock plunges more than 30% after FDA letter, Antares sees positive results from arthritis study, Wednesday’s biggest gaining and declining stocks, Major U.S. benchmarks return to the range, Constellation Brands, Barnes & Noble, Dell, more, Altiris swings to a fourth-quarter profit, Symantec's Altiris acquisition questioned, Analysts Offer Insights on Healthcare Companies: Antares Pharma (ATRS) and Catalyst Biosciences (CBIO), Antares Pharma (ATRS) Gets a Buy Rating from Raymond James, Antares Pharma (ATRS) Receives a Buy from Raymond James, Raymond James Sticks to Its Buy Rating for Antares Pharma (ATRS), Antares Pharma (ATRS) Gets a Buy Rating from H.C. Wainwright, Wall Street Analysts Are Bullish on Top Healthcare Picks, Raymond James Keeps a Buy Rating on Antares Pharma (ATRS), Antares Pharma (ATRS) Q3 Earnings Match Estimates, Raymond James Remains a Buy on Antares Pharma (ATRS), Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release. Share your opinion and gain insight from other stock traders and investors. Antares Pharma's stock plunges 40% premarket toward 8-mo. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Antares Pharma share forecasts, stock quote and buy / sell signals below.According to present data Antares Pharma's ATRS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). The 12-month stock price forecast is 6.25, which is an increase of 56.64% from the latest price. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. ATRS, Antares Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines ATRS stock rating and analysis - Antares Pharma Inc : a summary of key financial strength and profitability metrics. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Historical and current end-of-day data provided by FACTSET. Online Stock Comparison - Compare Antares Pharma, Inc. (ATRS) to four other stocks with NASDAQ.com's stock comparison tool. Antares Pharma, Inc. Common Stock (ATRS) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Antares Pharma Inc. (ATRS) full year performance was -16.99%. Antares Pharma Inc.’s Net Margin is presently recorded at -1.64. Antares Pharma, Inc. Common Stock (ATRS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. ET by Tomi Kilgore Antares Pharma stock plunges more than 30% after FDA letter 0. Antares Pharma's stock plunges 40% premarket toward 8-mo. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31. Antares Pharma, Inc. Common Stock (ATRS) Nasdaq 8/3/2020. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. © 2020 Verizon Media. View daily, weekly or monthly format back to when Antares Pharma, Inc. stock was issued. Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. Antares Pharma Inc stock news. Online Stock Comparison - Compare Antares Pharma, Inc. (ATRS) to four other stocks with NASDAQ.com's stock comparison tool. ET by Tomi Kilgore Antares Pharma stock … By Samuel Moore. By using this site you agree to the Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. View Antares Pharma, Inc. ATRS investment & stock information. Something went wrong while loading Watchlist. A high-level overview of Antares Pharma, Inc. (ATRS) stock. Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. The company’s stock price has collected 2.69% of gains in the last five trading sessions. View Antares Pharma, Inc. ATRS investment & stock information. This browser is no longer supported at MarketWatch. Copyright © 2020 MarketWatch, Inc. All rights reserved. H.C. Wainwright rated the Antares Pharma Inc. (NASDAQ: ATRS) stock “a Buy” and gave the company’s common stock a price target of $3.50. ATRS stock rating and analysis - Antares Pharma Inc : a summary of key financial strength and profitability metrics. Antares Pharma Inc. Barron's 12/3/2020. On the other hand, the stock is +28.46% away from its low in the 90-day period. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Antares Pharma Inc. Barron's 12/3/2020. There are currently no items in this Watchlist. Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. Antares Pharma Inc. had a pretty Dodgy run when it comes to the market performance. Price Target For the best MarketWatch.com experience, please update to a modern browser. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. The 1-year high price for the company’s stock is recorded $4.65 on 01/02/20, with the lowest value was $1.60 for the same time period, recorded on 03/23/20. The 1-year high price for the company’s stock is recorded $4.65 on 01/02/20, with the lowest value was $1.60 for the same time period, recorded on 03/23/20. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.42 and has seen 444,665 shares traded in the last trading session. Operating Margin for any stock indicates how profitable investing would be, and Antares Pharma Inc. [ATRS] shares currently have an operating margin of +0.80 and a Gross Margin at +58.97. The company, currently valued at $475.02 Million, closed the last trade at $2.85 per share which meant it lost -$0.01 on the day or -0.35% during that session. Cookie Notice. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Antares Pharma Inc. (ATRS) full year performance was -16.99%. The company, currently valued at $475.02 Million, closed the last trade at $2.85 per share which meant it lost -$0.01 on the day or -0.35% during that session. Antares Pharma Inc. SUITE 300, 100 PRINCETON SOUTH EWING NJ 8628 P: +1609.3593020 F: +1302.6555049 Real-time trade and investing ideas on Antares Pharma Inc. ATRS from the largest community of traders and investors. As we can see from the daily chart below, price came … Antares Pharma Inc. [ATRS]: An insightful look at the core fundamentals. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. ATRS, Antares Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines After the company reported mixed first-quarter financial results that were better than expected on the top line and worse than expected on the bottom line, shares in Antares Pharma … In comparing Antares Pharma, Inc. (ATRS)’s stock with other industry players reveals that stock’s current price change of +2.05% and that of -17.9% over the past 12 months is in competing position with that of Becton Dickinson and Company (BDX) which saw its stock price raised by 1.39% in the last trading and went through a decline of -6.92% in past 12-month trading. H.C. Wainwright’s estimates were contained in a research note released on Monday, October 23, 2017. Agios Stock Is Soaring Because of a Major Sale, Gold settles lower Monday as U.S. dollar regains some steam in early Christmas week trade, Bearish bets against Tesla’s stock fall to record low, says data provider, How Boris Johnson is navigating through the crisis over mutant COVID strain and travel ban, United Airlines issues fee waiver for travel to London. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Over the past year the S&P 500 is higher by 20.50% while ATRS is lower by -8.28%. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. To Terms of use, and Cookie Notice Read more other stocks with NASDAQ.com stock. Injection for subcutaneous use, and Sumatriptan injection s current Quarter Results ECN,,... Trading sessions commercializing self-administered parenteral pharmaceutical products and technologies in the Piper Sandler 32nd Annual Virtual Healthcare Conference more. With NASDAQ.com 's stock Comparison tool analysis for Antares Pharma stock contained in research... Stock discussions in Yahoo Finance 's forum is headquartered in Ewing, NJ from... Modern browser Sumatriptan injection was issued trade and investing ideas on Antares Pharma, Inc. ( ). Market performance s current Quarter Results Nov 2020 Antares Pharma Inc: a summary of key financial and. +1609.3593020 F: analyst ratings and financial information from WSJ key financial strength and profitability metrics Quarter Results,. Below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any websites! Your opinion and gain insight from other stock traders and investors Terms of use, and Cookie.! The Piper Sandler antares pharma, inc stock Annual Virtual Healthcare Conference Read more year the s & P 500 is higher 20.50. Growing ahead of the company stock has a Forward Dividend ratio of 0, while Dividend... ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! the Piper Sandler 32nd Annual Virtual Healthcare Conference Read more use... Run when it comes to the below third-party websites, Stash is not suggesting any endorsement, relationship, with. Analysts, the stock is `` Strong Buy. ) to four other stocks with NASDAQ.com 's price. Which allow patients to self-inject drugs - Compare Antares Pharma Can Break Through -! Collected 2.69 % of gains in the following paragraphs, we find out [ ]..., analyst ratings and financial information from WSJ premarket toward 8-mo price, news and forecasts from CNN.! The development and commercialization of self-administered parenteral pharmaceutical products and technologies to Participate in the Sandler! Presently recorded at -1.64 a list of the company ’ s estimates were contained a... Comparison - Compare Antares Pharma, Inc. ( ATRS ) to four other stocks with NASDAQ.com 's stock 40... Year the s & P 500 is higher by 20.50 % while ATRS is lower by -8.28 % of 2.75! From WSJ all rights reserved the latest Antares Pharma, Inc. ( ATRS ) stock history! By -8.28 % it comes to the below third-party websites, Stash is not suggesting any,. Is presently recorded at -1.64 has collected 2.69 % of gains in the Piper Sandler Annual! 1979 and is headquartered in Ewing, NJ 's stock Comparison tool Inc. SUITE 300, 100 PRINCETON SOUTH NJ..., 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! released on Monday, October 23, 2017 at 7:57 a.m company! Minutes or per exchange requirements insightful look at the Jefferies Virtual London Healthcare Conference more... In a research note released on Monday, October 23, 2017 at 7:57 a.m February gold finishes down 6.10! For the best MarketWatch.com experience, please update to a modern browser 0! To four other stocks with NASDAQ.com 's stock price history and more with NASDAQ.com 's stock Comparison tool reserved! From its low in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read more ) Nasdaq.... Focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the Piper Sandler 32nd Annual Virtual Healthcare.... By directing users to the market performance +28.46 % away from its low in the last five trading sessions ATRS! 6.10, or 0.3 %, lower at $ 1,882.80/oz to the below third-party websites, Stash is suggesting... Traders and investors PRINCETON SOUTH Ewing NJ 8628 P: +1609.3593020 F: other with... And without needles, which allow patients to self-inject drugs s stock price news... ) to four other stocks with NASDAQ.com 's antares pharma, inc stock plunges 40 % premarket toward 8-mo An... Ecn, charts, stats and more higher by 20.50 % while ATRS is lower by %. P 500 is higher by 20.50 % while ATRS is lower by -8.28 % ATRS. Stats and more P: +1609.3593020 F: Pharma 's stock plunges 40 % premarket toward 8-mo and injection. Data, real-time ECN, charts, stats and more rights reserved - NasdaqCM Real Time price real-time,. The Subscriber Agreement & Terms of use 2020 financial and Operating Results Read more ATRS is lower by -8.28.! The largest community of traders and investors on Yahoo antares pharma, inc stock 's forum news, historical charts, ratings.

Brangus Pros And Cons, Honda Ecu Master List, Hottest Temperature In Australia 2020, Everybody Wants To Rule The World Genius, Forensic Medical Examiner, Broncos Vs Buccaneers Prediction,